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Introduction
In 1951, the Durham-Humphrey Amendment was passed, requiring that any habit forming or potentially harmful drug must be dispensed under direct medical supervision by a healthcare practitioner. The amendment differentiated between legend (Rx) drugs and OTC drugs. Prescription drugs must carry the statement "Caution: Federal law prohibits dispensing without prescription." All other drugs have OTC status. Until this time, there was a lack of statutory direction and the responsibility of who designated what was a prescription or non-prescription, the FDA, regulated industry, or professional pharmacy, was undetermined. 1 In 1962, the Kefauver-Harris Amendments were passed, establishing a formal process that required drug manufacturers to clinically prove not only safety, but efficacy of medications and to report serious adverse events. This bill was likely in response to the crisis in 1962 of thalidomide, a morning sickness medication for pregnant women, which caused devastating birth defects in Europe. There were some limitations to the FDA. For example, the FDA couldn't prevent manufacturers from selling a drug if the FDA didn't act within 60 days of the drug's marketing. The FDA also Corresponding Author: Victor Phan, PharmD Candidate Temple University; Email: tud30762@temple.edu couldn't enforce good manufacturing processes and accurate prescription drug advertising before this act. More importantly, this act required FDA approval before a drug can be marketed in the US.
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With the Kefauver-Harris expansion of FDA authority, the Drug Efficacy Study Implementation (DESI) project was launched to evaluate the efficacy of drug products, including OTC, which reached the drug market from 1938 to 1962 that were initially based entirely on safety, prior to the 1962 FDA regulation amendments. 1, 3 In 1972, the FDA launched the OTC Drug Review to review the safety and efficacy of the ingredients, doses, formulations, and labeling used in medications available without prescription. 3 Rx-to-OTC switch is when a drug with prescription status (Rx) transfers to nonprescription over-the-counter (OTC) status for either the same or a related indication. Rx-to-OTC switch is a highly regulated process that allows consumers to have easier access to medications without having to go to the doctor. Some examples include nicotine replacement therapies (gum, patch, and lozenge), ibuprofen 200mg, Benadryl (diphenhydramine), Claritin (loratidine), Nexium (esomeprazole), and Flonase (fluticasone). 
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Some of the requirements for a drug to switch are that the drug must have a wide safety margin, efficacy, and easy to understand labeling and language to ensure proper use. Consumers must also be able to self-recognize and selfmedicate a condition, and to understand warnings. 4 There is definitely some conversation about the utility of the Rx-to-OTC switch. On the one hand, increasing access to frequently used medications with benign side effects that require prescriptions can lead to cost savings. The downside is that, even with benign side effects, many medications still require counseling or monitoring of some sort to maintain safety. In addition, patients need to be able to effectively self-diagnose to be successful in OTC therapy. One such study attempting to show the economic benefits was done estimating the potential switch of a triptan from Rx to OTC in France, UK, Spain, Italy, Germany, and Poland. This study took into account factors including time away from work, pathology, populations that tend to get migraines, and so on. What they found is that the overall spending for migraine attacks across the 6 countries came to $661 million annually with potential savings of 13% if only one triptan were to go OTC. The model in this study may not necessarily correlate in the US because of different healthcare spending methods (single-payer vs. multi-payer). 5 In a study of OTC Nicotine-Replacement-Therapy (NRT), it was found that the OTC availability of NRT increased access to and utilization of treatment with safe and efficacious use, and without substantial misuse or abuse. Prior to the switch, NRT was not widely used despite proven efficacy in smoking cessation. This study helped show that the Rx-to-OTC switch can increase utilization. This study may suggest potential for other switches to address public health needs. 6 OTC medication sales make up 8% of total US pharma sales volume. The availability of OTC medications has great value in the US healthcare system in the form of $102 billion in annual healthcare savings because of unneeded physician visits and diagnostic tests avoided. Currently, the OTC sector is about $40 billion in size. Rx-to-OTC switch category drugs accounted for 19% of OTC sales in the past 5 years.
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Study Methodology
The purpose of the study described here was a pilot study to This convenience sample is not intended to be generalizable, but rather is a pilot study to determine whether a larger, more diverse study might yield interesting and actionable results.
Findings
The demographics of the 101 surveyed are found in Table 1 . The results for the #1 question "What are some prescription only medications that you think would be okay to sell as nonprescription (over-the-counter and behind the counter)" are found in Table 2 . The results for the #2 question "If any, what are some OTC/BTC medications that you think should be prescription only?" are found in Table 3 .
Discussion
This discussion will focus mainly on the most frequent responses. By count, the most common response for Rx-to-OTC switch received was all oral contraceptives, where 40 out of 101 pharmacists responded. Of the 40 pharmacists, 26 were male and 14 were female. This finding may be potentiated due to the fact that oral contraceptives are a medication that females take, so males may not quite see the harm. It is also a possibility that since a majority of the respondents were from a retail setting, these suggestions were to ease the burden of refills and calls. However, 31 of the pharmacists had a Pharm.D. and 9 had a B.S. Pharmacists with a Pharm.D. degree have more extensive clinical knowledge of disease states and medications, which may lend support in the safety profile of oral contraceptives to switch them to OTC since the majority of respondents held a Pharm.D. Although there was no distinction between overthe-counter and behind-the-counter, oral contraceptives would likely be sold behind-the-counter because there are major counseling points associated with them, including but not limited to selecting the dosage of either the estrogen or progesterone component, medication adherence, and what to do with missed dosages.
The three most frequent medications following oral contraceptives are life-saving medications albuterol, epi-pen, and naloxone. One reason for these suggestions may be that albuterol and Epi-pen medications may frequently run out of refills or the prescriptions expire when they are needed because these medications aren't used consistently. Naloxone is an interesting suggestion; retail chains in PA are starting to obtain standing orders from physicians so that the pharmacist can prescribe naloxone. Nasonex nasal spray was the fifth most frequent, likely because Flonase is also OTC and they are similar.
The most frequent suggestion of OTC medications that should be moved to Rx was Plan B, with 10 out of 45 pharmacists that responded to this question. This is an interesting result because the most frequent suggestion for Rx-to-OTC switch was oral contraceptives. Of the 10 responses, 6 were males and 4 were females. 8 of the respondents had Pharm.D and 2 had B.S. 6 of the respondents included birth control as a suggestion, 5 of them being male and 1 female.
Although the suggestion of all herbals was second in frequency, this does not take into account specific herbal suggestions such as black cohosh, gingko biloba, ginseng, red yeast rice, and other herbals that may be thought of as supplements like weight loss supplements. This suggestion is likely due to the fact that there is little evidence of the efficacy of many herbal supplements. Many herbal supplements have known interactions with medications. There may also be many more unknown interactions with herbals alone or in combination with medications than the interactions known. Herbal supplements are less regulated than FDA approved medications and can pose a threat to patient safety.
Conclusion
There are many prescription medications that practicing pharmacists believe are safe to sell as OTC. 
Number of Suggestions per Response
One Suggestion 27
2-3 Suggestions 47
Over 4 Suggestions 27 *there was no distinction between retail chain and independent pharmacy
